Response to expression of concern regarding VIGOR study [2]

New England Journal of Medicine

Volumn 354, Issue 11, 2006, Pages 1198-1199

  Reicin, Alise ^a   Shapiro, Deborah ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NAPROXEN; ROFECOXIB;

CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; FOOD AND DRUG ADMINISTRATION; HEART INFARCTION; HUMAN; LETTER; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STROKE; THROMBOEMBOLISM;

EID: 33644979596     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Curfman GD, Morrissey S, Drazen JM. Expression of concern: Bombardier et al., "Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis," N Engl J Med 2000;343:1520-8.
2. N Engl J Med 2005;353:2813-4.
3. Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000;343:1520-8.